APA (7th ed.) Citation

RS, V., A, G., R, R., BC, G., D, C., C, S., . . . B, Y. (2018). Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 34(1-2), 161. https://doi.org/10.1089/jop.2016.0195

Chicago Style (17th ed.) Citation

RS, Verhoeven, Garcia A, Robeson R, Gilger BC, Culp D, Struble C, Hamm L, Navratil T, and Yerxa B. "Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery." Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics 34, no. 1-2 (2018): 161. https://doi.org/10.1089/jop.2016.0195.

MLA (9th ed.) Citation

RS, Verhoeven, et al. "Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery." Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics, vol. 34, no. 1-2, 2018, p. 161, https://doi.org/10.1089/jop.2016.0195.